Gilead’s TDF Drugs Allegedly Caused Serious Side Effects
We are filing lawsuits on behalf of people with HIV who took one or more of Gilead’s tenofovir disoproxil fumarate (TDF) drugs—Truvada, Viread, Atripla, Complera, and Stribild—and then allegedly suffered kidney disease and/or bone density loss.
Nearly 20,000 people with HIV were allegedly diagnosed with kidney disease after taking TDF-based antiretroviral drugs. Studies have also shown TDF drugs might cause an increased risk of bone fractures. Nearly 6,000 bone breaks are alleged to have been linked to the drug compound.
Gilead allegedly knew that TDF could cause serious side effects as early as 2001. In 2002, they allegedly tested a new formula—tenofovir alafenamide fumarate (TAF), later marketed as Genvoya and Odefsey—that achieves the therapeutic effect of TDF using a safer, lower dose. Allegedly, the new formula isn’t linked to the same risk of kidney and bone injuries that the earlier version has.
We’re Filing Suit on Behalf of People Allegedly Harmed by Gilead’s Actions
We’ve put together a powerful legal team dedicated to ensuring that Gilead takes responsibility for harm they allegedly caused and fairly compensates the people affected.
Our firms—Morgan & Morgan, Ben Crump Law, and Hilliard Martinez Gonzales—aim to hold Gilead accountable and recover money for patients who claim they were harmed by these drugs. Contact us today for a free, no-obligation legal review to see if you have a case.
Are You Eligible to Join the Lawsuit?
If you experienced one or more of the following injuries after taking Viread, Atripla, Complera, Stribild, or Truvada, you may be eligible to file a lawsuit.
- Chronic kidney disease (CKD) or declining kidney function
- Acute kidney injury (AKI) or acute renal failure (ARF)
- Fanconi syndrome
- Tubular dysfunction
- Bone fractures
YOU SHOULD SPEAK WITH YOUR DOCTOR BEFORE DISCONTINUING ANY MEDICATION.The Team